To further explore the relevant immune metastatic mechanism of SS, we utilized the GSE40021 dataset to divide patients into two groups (metastatic and nonmetastatic) and analyzed the following immune checkpoints: BTLA4, CTLA4, PD-1, PD-L1, and LAG3. The gene discussed is LAG3; the disease is synovial sarcoma.